编辑评论:洛萨坦可以预防临床显著的术后纤维化,但大型数据库研究可能无法提供答案
概括
洛萨坦是一种氨酸-血管激素系统调节剂,显示了在手术后预防关节硬的潜力. 需要进一步的研究来确认其在骨科手术中的抗纤维作用.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 像洛沙坦这样的宁-血管激素系统调节剂以抗纤维效应而闻名.
- 历史上被非外科医生用于心力衰竭和慢性病等疾病.
- 整形外科医生正在研究这些药物用于预防术后关节硬.
研究的目的:
- 探索洛萨坦和类似药物的潜力,以预防或减少术后关节硬.
- 评估对骨科手术后纤维化病的化学预防日益增长的兴趣.
主要方法:
- 审查现有文献,并探索数据库挖掘的局限性.
- 强调需要进行特定的临床试验来验证发现.
- 考虑除了洛萨坦之外的药物,具有类似的抗纤维化机制.
主要成果:
- 目前关于预防术后纤维化的研究结果相矛盾.
- 大规模的数据库挖掘可能不会提供临床上有意义的见解.
- 具体的试验对于最终答案至关重要.
结论:
- 需要进行严格的临床试验,以确定抗纤维素药物在骨科手术中的疗效.
- 未来的研究应该涵盖更广泛的氨酸-血管新生素系统调节剂.
- 了解纤维化在手术治疗中的复杂作用至关重要.
更多相关视频
08:21A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
4.6K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
579
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
579
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
472
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
472
01:25Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338